Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2009; 15(24): 3025-3031
Published online Jun 28, 2009. doi: 10.3748/wjg.15.3025
Published online Jun 28, 2009. doi: 10.3748/wjg.15.3025
Table 1 Baseline characteristics of 91 patients with chronic hepatitis B virus infection
Patient characteristics | HBeAg (+) Chronic hepatitis B n = 32 | HBeAg(-) hepatitis B | 1P | |
Inactive carriers n = 19 | HBeAg(-) chronic hepatitis n = 40 | |||
Gender (M/F) | 23/9 | 17/2 | 30/10 | 0.001 |
Age | 32 ± 11 | 39 ± 10 | 39 ± 10 | 0.010 |
BMI | 24.9 ± 2.5 | 25.1 ± 2.6 | 25.9 ± 2.0 | 0.300 |
Histological grade | 4.6 ± 1.9 (4-12) | ND | 4.4 ± 1.2 (4-18) | 0.500 |
Histological stage | 1.3 ± 1.4 (0-6) | ND | 1.1 ± 1.3 (0-6) | 0.500 |
ALT (IU/L) | 118 (16-190) | 24 (16-30) | 52 (20-116) | 0.001 |
AST (IU/L) | 71 (11-142) | 26 (16-34) | 38 (17-143) | 0.001 |
HBV DNA (median, copies/mL) | 1.9 × 1011 | 4150 | 2 × 105 | 0.001 |
Table 2 Validity of ALT, AST and serum HBV DNA levels for the differentiation of patients with HBeAg (-) chronic hepatitis B from inactive chronic HBsAg carriers
Laboratory test | SP % | SS % | PPV % | NPV % | Diagnostic accuracy % | Inactive carriers n = 19 | HBeAg(-) hepatitis B n = 40 |
ALT (> vs ≤ 2 ULN) | 100 | 33 | 100 | 41 | 54 | 0/19 | 27/13 |
ALT (> vs ≤ 1.3 ULN) | 47 | 90 | 78 | 69 | 78 | 10/9 | 36/4 |
AST > ULN | 84 | 45 | 86 | 42 | 58 | 3/16 | 22/18 |
HBV DNA (> vs < 50 000 copies/mL) | 57 | 73 | 97 | 62 | 80 | 1/18 | 29/11 |
HBV DNA 50 000 + ALT > (1.3 ULN) | 95 | 80 | 96 | 69 | 85 | 1/18 | 32/8 |
Table 3 Validity of HBV DNA levels for the differentiation of patients with HBeAg(-) chronic hepatitis B from inactive carriers and normal ALT values
HBV DNA levels (Copies/mL) | Specificity % | Sensitivity % | Predictive value % | Correct classification | Inactive carriers | HBeAg(-) hepatitis B | |
PPV | NPV | ||||||
HBV DNA > vs < 50 000 | 95 | 78 | 78 | 95 | 91 | 1/18 | 4/1 |
HBV DNA > vs < 100 000 | 95 | 78 | 78 | 95 | 91 | 1/18 | 4/1 |
HBV DNA > vs < 20 000 | 73 | 80 | 44 | 93 | 75 | 5/14 | 4/1 |
HBV DNA > vs < 5000 | 57 | 75 | 78 | 52 | 70 | 8/11 | 3/2 |
Table 4 Validity of ALT (ULN 30/19) and baseline serum HBV DNA levels for the differentiation of patients with HBeAg(-) chronic hepatitis B from inactive carriers
Laboratory test | SP % | SS % | PPV % | NPV % | Diagnostic accuracy % | Inactive carriers n = 19 | HBeAg(-) hepatitis B n = 40 |
ALT (> vs ≤ 30 M/19 F) | 100 | 92 | 100 | 86 | 95 | 0/19 | 37/3 |
HBV DNA (> vs ≤ 100 000 copies/mL) | 73 | 72 | 85 | 56 | 72 | 5/14 | 29/11 |
ALT+ HBV DNA | 100 | 92 | 100 | 86 | 95 | 0/19 | 37/3 |
- Citation: Assy N, Beniashvili Z, Djibre A, Nasser G, Grosovski M, Nseir W. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg(-) chronic hepatitis B patients from inactive chronic carriers. World J Gastroenterol 2009; 15(24): 3025-3031
- URL: https://www.wjgnet.com/1007-9327/full/v15/i24/3025.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3025